Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Harnessing the Power of Oncolytic Viruses

September 03, 2023

Tumour-infiltrating lymphocyte (TIL) therapies offer a new route to target cancer.

Booster Shot for Pharma

September 02, 2023

European vaccine manufacturing is being boosted with high level investments.

Drug Solutions Podcast: mRNA Past, Present, and Future

August 17, 2023

An mRNA conversation about the recent past, current hot topics, and probable future.

Miniaturing Personalized Cancer Vaccines Through mRNA

August 17, 2023

Experts discuss the promise of personalized cancer vaccines through the inherent nimbleness of mRNA platform.

Charting the Future of Vaccines

August 03, 2023

A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.

Ensuring OSD Quality and Safety

August 02, 2023

Current good manufacturing practices for oral solid dosage forms protect the product from contamination and potential errors.

Teva Pharmaceuticals and Alvotech Expand Existing Biosimilars Partnership

July 27, 2023

Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.

Drug Solutions Podcast: Evaluating the Vaccine Marketplace

July 18, 2023

Jeff Fischer, co-founder and president of Longhorn Vaccines and Diagnostics, discusses the history and ongoing development of both protein- and mRNA-based vaccines.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

July 11, 2023

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Using Analytical Advancements to Assess Biosimilarity

July 05, 2023

When evaluating a drug’s risk assessment for elemental impurities, one must consider all aspects of its lifecycle.